CORE-OLE: A Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Participants With Severe Hypertriglyceridemia (SHTG)
Clinical trial NCT05681351 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05681351
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-13
- Primary completion
- 2027-03-01
- Enrollment
- 885
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.